Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin

Magnetic Resonance in Medicine

Volumn 48, Issue 5, 2002, Pages 819-825

  Glunde, Kristine ^a   Ackerstaff, Ellen ^a   Natarajan, Kshama ^a   Artemov, Dmitri ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1H; 31P NMR; Anti inflammatory agent; Breast cancer; Choline compounds; Intracellular pH

Indexed keywords

BIOMOLECULES; CYTOLOGY; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPIDS;

31P-NMR; ANTI-INFLAMMATORY AGENTS; BREAST CANCER; CHOLINE COMPOUNDS; INTRACELLULAR PH;

CELLS;

CELL EXTRACT; CHOLINE; GLYCEROPHOSPHORYLCHOLINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PROSTAGLANDIN SYNTHASE;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL PH; DIFFUSION WEIGHTED IMAGING; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0036847446     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10295     Document Type: Article

References (43)

1. Podo F. Tumour phospholipid metabolism. NMR Biomed 1999;12:413-439.
2. de Certaines JD, Larsen VA, Podo F, Carpinelli G, Briot O, Henriksen O. In vivo 31P MRS of experimental tumours. NMR Biomed 1993;6:345-365.
3. Negendank W. Studies of human tumors by MRS: A review. NMR Biomed 1992;5:303-324.
4. Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, Radda GK. Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 1986;2:8-11.
5. Leach MO, Verrill M, Glaholm J, Smith TA, Collins DJ, Payne GS, Sharp JC, Ronen SM, McCready VR, Powles TJ, Smith IE. Measurements of human breast cancer using magnetic resonance spectroscopy: A review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed 1998;11:314-340.
6. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992;5:226-233.
7. Ting YL, Sherr D, Degani H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996;16:1381-1388.
8. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-84.
9. Natarajan K, Mori N, Artemov D, Aboagye EO, Chacko VP, Bhuiwalla ZM. Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin. Adv Enzyme Regul 2000;40:271-284.
10. Connolly JM, Liu XH, Rose DP. Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr Cancer 1996;25:231-240.
11. Reich R, Martin GR. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins 1996;51:1-17.
12. Rozic JG, Chakraborty C, Lala PK. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 2001;93:497-506.
13. Rose DP, Connolly JM. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 2000;37:119-127.
14. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000;19:19-27.
15. Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 1999;79:1469-1477.
16. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-1423.
17. Vane JR, Botting RM. Mechanism of action of antiinflammatory drugs. Int J Tissue React 1998;20:3-15.
18. Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot Essent Fatty Acids 1996;54:83-94.
19. Marks F, Muller-Decker K, Furstenberger G. A causal relationship between unscheduled eicosanoid signaling and tumor development: Cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 2000;153:11-26.
20. Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, Lyn P, Leavy J, Witte L, Joseph-Silverstein J, Furie MB, Torcia G, Cozzolino F, Kamada T, Stern DM. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 1995;92:4606-4610.
21. Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ. The effect of surgical wounding on tumour development. Eur J Surg Oncol 1999;25:231-243.
22. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995;107:233-235.
23. Galons JP, Job C, Gillies RJ. Increase of GPC levels in cultured mammalian cells during acidosis. A 31P MR spectroscopy study using a continuous bioreactor system. Magn Reson Med 1995;33:422-426.
24. Pilatus U, Aboagye E, Artemov D, Mori N, Ackerstaff E, Bhujwalla ZM. Real-time measurements of cellular oxygen consumption, pH, and energy metabolism using nuclear magnetic resonance spectroscopy. Magn Reson Med 2001;45:749-755.
25. Roos A, Boron WF. Intracellular pH. Physiol Rev 1981;61:296-434.
26. Rothman DL, Behar KL, Hetherington HP, Shulman RG. Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci USA 1984;81:6330-6334.
27. Van Zijl PC, Moonen CT, Faustino P, Pekar J, Kaplan O, Cohen JS. Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy. Proc Natl Acad Sci USA 1991;88:3228-3232.
28. Dufour S, Thiaudiere E, Vidal G, Gallis JL, Rousse N, Canioni P. Temperature dependence of NMR relaxation times of nucleoside triphosphates and inorganic phosphate in the isolated perfused rat liver. Effect on Pi compartmentation. J Magn Reson B 1996;113:125-135.
29. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: Quantification of 18 metabolites in short-echotime (1)H NMR spectra of the rat brain. J Magn Reson 1999;141:104-120.
30. Prichard JW, Alger JR, Behar KL, Petroff OA, Shulman RG. Cerebral metabolic studies in vivo by 31P NMR. Proc Natl Acad Sci USA 1983;80:2748-2751.
31. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase-2: A target for the prevention and treatment of breast cancer. Endocr Relat Cancer 2001;8:97-114.
32. O'Byrne KJ, Dalgleish AG, Browning MJ, Steward WP, Harris AL. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000;36:151-169.
33. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 2000;97:11280-11285.
34. Yeung DK, Cheung HS, Tse GM. Human breast lesions: Characterization with contrast-enhanced in vivo proton MR spectroscopy - Initial results. Radiology 2001;220:40-46.
35. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 1996:16:1375-1380.
36. Noh DY, Ahn SJ, Lee RA, Park IA, Kim JH, Suh PG, Ryu SH, Lee KH, Han JS. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett 2000;161:207-214.
37. Guthridge CJ, Stampfer MR, Clark MA, Steiner MR. Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells. Cancer Lett 1994;86:11-21.
38. Price BD, Morris JD, Hall A. Stimulation of phosphatidylcholine break-down and diacylglycerol production by growth factors in Swiss-3T3 cells. Biochem J 1989;264:509-515.
39. Bogin L, Papa MZ, Polak-Charcon S, Degani H. TNF-induced modulations of phospholipid metabolism in human breast cancer cells. Biochim Biophys Acta 1998;1392:217-232.
40. Ronen SM, Jackson LE, Beloueche M, Leach MO. Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells. Br J Cancer 2001;84:691-696.
41. Kiss Z, Crilly KS, Anderson WH. Carcinogens stimulate phosphorylation of ethanolamine derived from increased hydrolysis of phosphatidylethanolamine in C3H/101/2 fibroblasts. FEBS Lett 1993;336:115-118.
42. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989:49:6449-6465.
43. Sterin M, Cohen JS, Mardor Y, Berman E, Ringel I. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: A (31)p-magnetic resonance spectroscopy study. Cancer Res 2001;61:7536-7543.